Background—Therapies for patients with chronic heart failure caused by left ventricular
systolic dysfunction have advanced substantially over recent decades. The cumulative effect …

Heart failure management is complex and constantly evolving. The American College of
Cardiology and the American Heart Association (ACC/AHA) last issued evidence-based …

Improvements in the management of acute myocardial infarction together with population
ageing have contributed to a growing burden of heart failure. Around half of new cases of …

Mortality rates for patients with acute myocardial infarction (MI) continue to decline as
evidence-based therapies are implemented on a broader scale, invasive management and …

For decades heart failure therapy has focused on symptomatic treatment, whereas
preventive aspects have received less attention. However, 10 years of large controlled trials …

Sudden death characterizes the mode of demise in 30–50% of patients with chronic heart
failure and a reduced ejection fraction. Occasionally, these events have an identifiable …

Medical therapy remains the first and, for the majority of patients, only option for the
treatment of chronic heart failure and left ventricular dysfunction. This article reviews the …

Aims We analysed the contemporary incidence, outcomes, and predictors of heart failure
(HF) and/or left ventricular systolic dysfunction (LVSD) before discharge in patients with …

Many conditions culminate in heart failure (HF), a multi‐organ systemic syndrome with an
intrinsically poor prognosis. Pharmacotherapeutic agents that correct neurohormonal …